Company profile · Sponsor
Xilio
Xilio Therapeutics
- Pipeline
- 3
- Drugs
- 0
- Patents
- 7
Quick answer
Xilio (XLO) is a pharma company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 7 patents to this profile..
Company facts
Pipeline (3)
Search pipeline →Patents (7)
Search patents →-
US 12384845
Activatable masked anti-CTLA4 binding proteins
granted -
US 12280120
Tumor-specific cleavable linkers
granted -
US 11866476
Masked IL-2-Fc fusion polypeptides
granted -
US 11827686
Masked cytokine polypeptides
granted -
US 11827685
Masked cytokine polypeptides
granted -
US 11718655
Masked interleukin-12 polypeptides
granted -
US 11053294
Masked cytokine polypeptides
granted
Frequently asked questions
What is Xilio?
Xilio (XLO) is a pharma company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 7 patents to this profile..
What pipeline programs does Xilio sponsor?
We track 3 ClinicalTrials.gov-linked programs for Xilio, including XTX202 and 2 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Xilio company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.